The nonlinear relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease

被引:3
|
作者
Hu, Yingying [1 ,2 ]
Zhou, Fan [3 ,4 ]
Lei, Fang [2 ,5 ]
Lin, Lijin [1 ,2 ]
Huang, Xuewei [6 ]
Sun, Tao [1 ,2 ]
Liu, Weifang [1 ,2 ]
Zhang, Xingyuan [2 ,5 ]
Cai, Jingjing [2 ,6 ]
She, Zhi-Gang [1 ,2 ]
Li, Hongliang [1 ,2 ]
机构
[1] Wuhan Univ, Renmin Hosp, Dept Cardiol, Wuhan, Peoples R China
[2] Wuhan Univ, Inst Model Anim, Wuhan, Peoples R China
[3] Yangtze Univ, Huanggang Cent Hosp, Dept Gastroenterol, Huanggang, Peoples R China
[4] Huanggang Inst Translat Med, Huanggang, Peoples R China
[5] Wuhan Univ, Sch Basic Med Sci, Wuhan, Peoples R China
[6] Cent South Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Peoples R China
来源
FRONTIERS IN ENDOCRINOLOGY | 2023年 / 14卷
基金
美国国家科学基金会;
关键词
metabolic dysfunction-associated fatty liver disease; thyroid function parameters; nonlinear relationship; restricted cubic spline analysis; multivariable-adjusted logistic regression models; STIMULATES LEPTIN SECRETION; FREE TRIIODOTHYRONINE; ADIPOSE-TISSUE; HORMONE; RISK; NAFLD; HYPOTHYROIDISM; PATHOGENESIS; THYROTROPIN; PREVALENCE;
D O I
10.3389/fendo.2023.1115354
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
BackgroundThe relationship between thyroid function parameters and metabolic dysfunction-associated fatty liver disease (MAFLD) remains controversial. Additionally, little is known about the relationship between thyroid function parameters and MAFLD in the Chinese population. MethodsWe conducted a retrospective cross-sectional study involving 177,540 individuals with thyroid function tests and MAFLD diagnosis from 2010-2018. The association between thyroid function parameters and MAFLD was evaluated on a continuous scale with restricted cubic spline (RCS) models and by the prior-defined centile categories with multivariable-adjusted logistic regression models. Thyroid function parameters included free triiodothyronine (FT3), free tetra-iodothyronine (FT4), and thyroid stimulating hormone (TSH). Additionally, fully adjusted RCS models stratified by sex, age, and location were studied. ResultsIn the RCS models, the risk of MAFLD increased with higher levels of FT3 when FT3 <5.58pmol/L, while the risk of MAFLD decreased with higher levels of FT3 when FT3 >= 5.58pmol/L (P nonlinearity <0.05). While RCS analysis suggested that the FT4 levels had a negative association with MAFLD (P nonlinearity <0.05), indicating an increase in FT4 levels was associated with a decreased risk of MAFLD. RCS analysis suggested an overall positive association between the concentration of TSH and MAFLD risk (P nonlinearity <0.05). The rising slope was sharper when the TSH concentration was less than 1.79uIU/mL, which indicated the association between TSH and MAFLD risk was tightly interrelated within this range. The multivariable logistic regression showed that populations in the 81st-95th centile had the highest risk of MAFLD among all centiles of FT3/TSH, with the 1st-5th centile as the reference category. ConclusionsOur study suggested nonlinear relationships between thyroid function parameters and MAFLD. Thyroid function parameters could be additional modifiable risk factors apart from the proven risk factors to steer new avenues regarding MAFLD prevention and treatment.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Relationship between Non-alcoholic Fatty Liver Disease and Thyroid Dysfunction
    Nakade, Yukiomi
    Yoneda, Masashi
    INTERNAL MEDICINE, 2016, 55 (15) : 1941 - 1942
  • [32] Update in lean metabolic dysfunction-associated steatotic liver disease
    Sato-Espinoza, Karina
    Chotiprasidhi, Perapa
    Huaman, Mariella R.
    Diaz-Ferrer, Javier
    WORLD JOURNAL OF HEPATOLOGY, 2024, 16 (03) : 452 - 464
  • [33] Quality of Life in Adults with Metabolic Dysfunction-Associated Fatty Liver Disease
    Hwang, Tae-In
    Han, A-Lum
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (24)
  • [34] Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease
    Alam, Shahinul
    Fahim, Shah Mohammad
    WORLD JOURNAL OF HEPATOLOGY, 2021, 13 (10) : 1203 - 1207
  • [35] Effect of Immunosuppressive Regimens on Metabolic Dysfunction-associated Fatty Liver Disease Following Liver Transplantation
    Kang, Jing
    Zhu, Ji-Qiao
    Wang, Yan
    He, Qiang
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2025, 15 (01)
  • [36] Relationship between Adipokines and Cardiovascular Ultrasound Parameters in Metabolic-Dysfunction-Associated Fatty Liver Disease
    Ismaiel, Abdulrahman
    Spinu, Mihail
    Budisan, Livia
    Leucuta, Daniel-Corneliu
    Popa, Stefan-Lucian
    Chis, Bogdan Augustin
    Berindan-Neagoe, Ioana
    Olinic, Dan Mircea
    Dumitrascu, Dan L.
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (21)
  • [37] Metabolic dysfunction-associated fatty liver disease: current therapeutic strategies
    Al Hashmi, Khamis
    Giglio, Rosaria Vincenza
    Stoian, Anca Pantea
    Patti, Angelo Maria
    Al Waili, Khalid
    Al Rasadi, Khalid
    Ciaccio, Marcello
    Rizzo, Manfredi
    FRONTIERS IN NUTRITION, 2024, 11
  • [38] Metabolic Dysfunction-associated Fatty Liver Disease (MAFLD) and Viral Hepatitis
    Wang, Xiaolin
    Xie, Qing
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2022, 10 (01) : 128 - 133
  • [39] Metabolic Dysfunction-Associated Fatty Liver Disease, Statins, and Atherosclerotic Cardiovascular Disease
    Chang, Hui-Chin
    Gau, Shuo-Yan
    AMERICAN JOURNAL OF MEDICINE, 2024, 137 (01): : E14 - E14
  • [40] Guideline for the Prevention and Treatment of Metabolic Dysfunction-associated Fatty Liver Disease (Version 2024)
    Fan, Jian-Gao
    Xu, Xiao-Yuan
    Yang, Rui-Xu
    Nan, Yue-Min
    Wei, Lai
    Jia, Ji-Dong
    Zhuang, Hui
    Shi, Jun-Ping
    Li, Xiao-Ying
    Sun, Chao
    Li, Jie
    Wong, Vincent Wai-Sun
    Duan, Zhong-Ping
    JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY, 2024, 12 (11) : 955 - 974